Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Many precision current source designs are available, but simple arithmetic for component values to tailor them for an ...
Nuclear fusion, which operates on the same principle that powers the sun, is expected to become a sustainable energy source for the future. To achieve fusion power generation, it is essential to ...
Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback